Carbapenem-Based Antibiotics Market Size, Scope, and Share by 2028
Carbapenem-Based Antibiotics Market: Strategic Insights
Carbapenem-Based Antibiotics Market
-
CAGR (2021 - 2028)4.4% -
Market Size 2021
US$ 3.96 Billion -
Market Size 2028
US$ 5.35 Billion
Market Dynamics
GROWTH DRIVERS
- Rising prevalence of bacterial infections
- Increased demand for last-resort antibiotics
- Growth in hospital-acquired infections
FUTURE TRENDS
- Focus on antibiotic stewardship programs
- Increased research on resistant pathogens
- Development of combination therapies
OPPORTUNITIES
- Development of novel carbapenem derivatives
- Demand in emerging markets healthcare
- Expansion in injectable antibiotic formats
Key Players
- Pfizer Inc
- Savior Lifetec
- Sumitomo Dainippon Pharma Co Ltd
- Merck Co Inc
- Gland Pharma Limited
- Aurobindo Pharma Ltd
- Daewoong Pharmaceutical Co Ltd
- Iterum Therapeutics plc
- ACS Dobfar S p A
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type - Meropenem
- Doripenem
- Imipenem
- Tebipenem
Indication - Bacterial Meningitis
- Acute Pelvic Infections
- Respiratory Tract Infections
- Intra-Abdominal Infections
- Urinary Tract Infections
Distribution Channel - Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Get Free Sample For